A new variant of the SARS-CoV-2 virus, known as Nimbus, has raised concerns among virologists due to its potential for increased transmission and severity. The World Health Organization (WHO) has designated Nimbus a “variant under monitoring” after it was detected in Asia, the US, Europe, and Canada.
Nimbus has recombined genetic material from other strains three times, allowing it to evade immunity built up against previous infections. However, its potential for higher transmissibility remains uncertain. While there’s no evidence linking Nimbus to more severe illness, experts warn that high transmissibility can cause significant damage.
Recent cases of “razor blade throat” have sparked debate about the symptoms’ connection to COVID or other viruses. The virus continues to evolve, with current data showing most infections in the US are caused by variants Pirola and LP.8.1.
Vaccine access may be limited this fall due to updated guidelines from the FDA, which could reduce insurance coverage and availability. Experts caution that these changes may lead fewer people to get vaccinated, leaving those without insurance or at risk for severe illness vulnerable.
As COVID continues to pose a threat, especially for those with existing conditions like diabetes, obesity, and heart disease, it’s essential to protect against long-term consequences of the virus. Continuous surveillance and research funding are crucial in preparing for future variants.
Source: https://www.salon.com/2025/06/11/razor-blade-throat-the-nimbus-variant-sparks-concern-of-summer-surge